Raymond Walls, MD
Foot and Ankle Surgery · New York, NYNPI 1164763306
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Linvatec Corporation accounts for 65.1% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $11,211, more than ten times the $357 reported in 2019. Among foot and ankle surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 69 payments — averaging $436.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Linvatec Corporation$20K
- Stryker$3K
- In2bones USA, LLC$3K
- Zimmer Biomet$2K
- Gotham Surgical Solutions & Devices, Inc.$1K
- Arteriocyte Medical Systems, Inc.$518
- plus $412 from 7 others
What the payments were for
- Royalty or licence$1,1324%
- Consulting fees$16,10053%
- Speaking & faculty fees$1,0003%
- Grants$2,5008%
- Travel & lodging$3,88813%
- Food & beverage$3,51812%
- Education$1,9747%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Linvatec Corporation | 19 | $19,608 |
| Stryker(2 entities) | 24 | $3,263 |
| In2bones USA, LLC | 3 | $2,719 |
| Zimmer Biomet | 10 | $2,339 |
| Gotham Surgical Solutions & Devices, Inc. | 2 | $1,253 |
| Arteriocyte Medical Systems, Inc. | 2 | $518 |
| Treace Medical Concepts, Inc. | 2 | $146 |
| Restor3d, Inc. | 1 | $118 |
| Extremity Medical | 1 | $72 |
| Orthofix Medical, Inc. | 2 | $25 |
| Tenex Health Inc. | 1 | $24 |
| Bioventus LLC | 1 | $14 |
| Smith+Nephew | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALLOGRAFT TISSUE$9,132
- QUANTUM$6,043
- CARTIMAX$3,500
- Quantum Total Ankle$2,719
- ArchiMIS$1,350
- AXS INFINITY LS$774
- Trabecular Metal (TM)$769
- BioBrace 23mm$645
- INBONE$595
- AUGMENT INJECTABLE$565
- HOFFMANN$420
- HERCULES SUTURE ANCHOR SYSTEM$309
- INFINITY$307
- PROPHECY$290
- AXSOS$287
- VARIAX$287
- GAMMA$287
- PROSTEP MICA$277
- Magellan$255
- Influx$255
How this compares
$30,112 in reported general payments places this provider in the 90th percentile of 652 foot and ankle surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 53 | $571 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in New York
- Jonathan DelandNew York$4M
- Constantine DemetracopoulosNew York$888K
- Anne JohnsonNew York$815K
- Scott EllisNew York$597K
- John KennedyNew York$534K
- Stuart MogulNew York$131K
- Deena HornNew York$93K
- John DoolanNew York$87K
- Jason SnyderNew York$79K
- Meghan KellyNew York$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.